Eduardas Vilkas

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

   · 2019 · cited 1,477x

2. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

   · 2018 · cited 699x

3. Industry 4.0, innovation, and sustainable development: A systematic review and a roadmap to sustainable innovation

   · 2021 · cited 390x

4. Advantages of Volunteer‐Based Biodiversity Monitoring in Europe

   · 2009 · cited 282x

5. Enantiomerically Enriched Allylic Alcohols and Allylic Amines via C–C Bond-Forming Hydrogenation: Asymmetric Carbonyl and Imine Vinylation

   · 2007 · cited 282x

via Crossref · CC0